Note 8 - Segment Information

3 Months Ended

Sep. 30, 2017

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

8.

Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company

’s operating segments.

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing,

Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the

three

months ended

September 30, 2017

and

2016

were

$1,658

and

$2,876,

respectively.

Financial information relating to the

three

months ended

September 30, 2017

and

2016

operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract	2017	$	7,822	$	1,583	$	9,405	$	835	$	74	$	93
Manufacturing	2016		9,321		2,711		12,032		1,897		71		41
Branded Proprietary	2017		19		11		30		32		1		13
Products	2016		30		95		125		34		-		-
Other Nutraceutical	2017		271		64		335		138		-		1
Businesses	2016		454		70		524		221		1		-
Total	2017		8,112		1,658		9,770		1,005		75		107
Company	2016		9,805		2,876		12,681		2,152		72		41

	Total Assets as of
	September 30,		June 30,
	2017		2017
Contract Manufacturing	$	10,426	$	12,134
Branded Proprietary Products		804		784
Other Nutraceutical Businesses		2,151		2,278
Total Company	$	13,381	$	15,196